MEDINET 2370

メディネット

Recent Updates

2022-11-16

Launches a joint clinical study with Seta Clinic Tokyo regarding αβT-cell therapy in patients not responsive to immune checkpoint inhibitors

2022-11-14

Full-year FY09/22 flash update

2022-10-18

US-based BioLegend commences sales of the company's monoclonal antibody

Get in touch

Address:TRC Center Bldg, 9F 6-1-1 Heiwajima, Ota-ku Tokyo, Japan 143-0006

Website:https://www.medinet-inc.co.jp/english/ir/

Summary

Shifting from Immuno-Cell Therapy Total Support Service to the Contracted Cell Manufacturing Business; sale and development of cell medicinal products

Key dates

2010-09-30

Coverage initiation